N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide

N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide Suppliers list
Company Name: Wuhan Jingkangen Biomedical Technology Co., Ltd  
Tel: 13720134139 086-15871494362 13720134139
Email: orders@jknbiochem.com
Company Name: Changsha Fuzhen Biotechnology Co.,LTD  
Tel: 15111215862 18229892877
Email: 3062105966@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Olix ( Hubei) Pharmaceutical Technology Co., Ltd  
Tel: 17316404525 17316404525
Email: 209533805@qq.com
Company Name: Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd.  
Tel: 025-66061636 19370895928
Email: qqyang@aikonchem.com
N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide Basic information
Product Name:N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide
Synonyms:N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide;N-(2-Chloro-6-fluorobenzyl)-5-(1H-indazol-3-yl)thiophene-3-carboxamide;XMU-MP-9
CAS:2251130-41-1
MF:C19H13ClFN3OS
MW:385.84
EINECS:
Product Categories:
Mol File:2251130-41-1.mol
N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide Structure
N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide Chemical Properties
Boiling point 634.8±55.0 °C(Predicted)
density 1.444±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
pka13.05±0.40(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide Usage And Synthesis
UsesXMU-MP-9 is a bifunctional compound that binds to the C2 domain of Nedd4-1 and the allosteric site of K-Ras. XMU-MP-9 enhances the interaction between Nedd4-1 and K-Ras, induces conformational changes in the Nedd4-1/K-Ras complex, promotes the ubiquitination and degradation of multiple K-Ras mutants, and inhibits the proliferation of cells carrying K-Ras mutants. XMU-MP-9 can be used in cancer research[1].
References[1] Taoling Zeng, et al. "Targeting oncogenic K-Ras mutants with a small-molecule degrader through Nedd4-1."bioRxiv(2024): 2024-04.
N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide Preparation Products And Raw materials
Tag:N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide(2251130-41-1) Related Product Information
3-Thiophenecarboxamide, 5-(6-amino-1H-indazol-3-yl)-N-[(2-chloro-6-fluorophenyl)methyl]- 3-Thiophenecarboxamide, N-[(2-chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-, 2,2,2-trifluoroacetate (1:1) N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide 2-Propen-1-one, 1-[(3S)-4-[(7R)-7-[6-amino-4-methyl-3-(trifluoromethyl)-2-pyridinyl]-6-chloro-8-fluoro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]-4-quinazolinyl]-3-methyl-1-piperazinyl]- 2,7-Diazaspiro[4.4]nonane-2-acetamide, α-cyclopentyl-7-[[(2R,3R)-3-cyclopropyl-1-methyl-2-aziridinyl]carbonyl]-N-[(1R,10S,12S,18S)-1-[5-(4-cyclopropyl-1-piperazinyl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-2,7,8,10,11,12,13,16,17,18,19,21,22,23-tetradecahydro-22,22-dimethyl-13,19-dioxo-2-(2,2,2-trifluoroethyl)-15H-3,5-etheno-14,18-imino-6,10-methano-6H-pyrrolo[3,4-g][1,12,4,18]dioxadiazacyclodocosin-12-yl]-, (αS,5S)- NAV2729